Skip to main content

Table 3 Recurrent identical amplicons observed in at least two tumors

From: Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity

Chromosome Start positiona End positiona Candidate genes Maximum ratio Number of cases
      MBC BLC
1q21.2–21.3 148.109 150.70 SNX27, FLG, S100, LRN 2.2 3 0
8p11.21 40.01 42.35 MYST3, ANK1 2.9 3 0
8q24 122.64 128.80 MYC, KIAA0196 2.3 2 2
10p15.3 0.25 1.00 ZMYND11 2.3 3 0
12p13.32–13.33 2.46 4.31 CCND2 2.8 2 0
12p13.2-13.31 5.16 6.37 TNFRSF1A, NTF3, LTBR, CD9 2.7 3 0
12p13.2 7.80 11.7 PRR4, Nanog, CD69, STELLA/DPPA3, PHC1 3.8 3 0
12p13.2 11.95 12.11 ETV6, BCL2L14 9.1 3 0
Xp11.22 51.21 53.95 SSX1, SSX2 2.8 0 2
Xq28 152.66 153.69 MTCP1, TZ, TKTL1, FLNA 2.8 3 1
  1. MBC, medullary breast carcinoma; BLC, basal-like carcinoma. aUCSC Genome Browser on Human May 2004 Assembly; positions are given in megabases.